Susan Wade
Corporate Officer/Principal bei Cartilix, Inc.
Profil
Susan Wade is Head of Quality Assurance and Quality Control for Cartilix, Inc. Previously, she worked at Cell Genesys, Inc., Syntex Corp., Collagen Corp., and Orquest, Inc. Ms. Wade received a BA degree in Biochemistry from California State University-East Bay.
Aktive Positionen von Susan Wade
| Unternehmen | Position | Beginn |
|---|---|---|
Cartilix, Inc.
 Cartilix, Inc. Medical SpecialtiesHealth Technology Cartilix, Inc. develops surgical devices and associated biomaterials to treat focal cartilage defects in joints. Its technology is used in wound sealing solutions, spinal disc regeneration, and other biological interfaces. The company was founded by Frank Huerta, Norman A. Marcus, and Jennifer Elisseeff in July 2004 and is headquartered in Foster City, CA | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Susan Wade
| Unternehmen | Position | Ende |
|---|---|---|
Orquest, Inc.
 Orquest, Inc. Medical SpecialtiesHealth Technology Orquest, Inc. developed and manufactured bone graft materials. Its technology HEALOS Bone Graft Material, was designed and developed to reduce the time and pain associated with standard bone graft harvesting. Orquest was located in Mountain View, CA. | Corporate Officer/Principal | - |
| Syntex Corp. | Corporate Officer/Principal | - |
| Collagen Corp. | Corporate Officer/Principal | - |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - |
Ausbildung von Susan Wade
| California State University-East Bay | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Cartilix, Inc.
Cartilix, Inc. Medical SpecialtiesHealth Technology Cartilix, Inc. develops surgical devices and associated biomaterials to treat focal cartilage defects in joints. Its technology is used in wound sealing solutions, spinal disc regeneration, and other biological interfaces. The company was founded by Frank Huerta, Norman A. Marcus, and Jennifer Elisseeff in July 2004 and is headquartered in Foster City, CA | Health Technology |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
| Syntex Corp. | Health Technology |
| Collagen Corp. | Health Technology |
Orquest, Inc.
Orquest, Inc. Medical SpecialtiesHealth Technology Orquest, Inc. developed and manufactured bone graft materials. Its technology HEALOS Bone Graft Material, was designed and developed to reduce the time and pain associated with standard bone graft harvesting. Orquest was located in Mountain View, CA. | Health Technology |
